Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, BW; Richtig, G; Scharnagl, H; Meinitzer, A; Pieske, B; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S.
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
J Clin Hypertens (Greenwich). 2016; 18(7):608-13
Doi: 10.1111/jch.12825
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Grübler Martin
- Co-Autor*innen der Med Uni Graz
-
Fahrleitner-Pammer Astrid
-
Keppel Martin
-
Kienreich Katharina
-
März Winfried
-
Meinitzer Andreas
-
Pieske Burkert Mathias
-
Pilz Stefan
-
Richtig Georg
-
Scharnagl Hubert
-
Schmid Johannes
-
Tomaschitz Andreas
-
Verheyen Nicolas Dominik
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Increasing evidence describes a possible interplay between vitamin D insufficiency with increased aldosterone. The authors sought to evaluate the effect of vitamin D supplementation on plasma aldosterone concentration (PAC) in patients with hypertension and 25-hydroxyvitamin D[25(OH)D] insufficiency. The Styrian Vitamin D Hypertension Trial was a single-center, double-blind, placebo-controlled randomized clinical trial conducted from 2011 to 2014. Two hundred patients with arterial hypertension and 25(OH)D levels <30 ng/mL were enrolled. Study participants were randomized to receive either 2800 IU of vitamin D3 or placebo. The present investigation is a post hoc analysis using analysis of covariance adjusting for baseline differences. A total of 188 participants (mean±standard deviation age, 60.1±11.3 years; 47% women; 25(OH)D, 21.2±5.6 ng/mL) completed the trial. Mean differences between baseline and follow-up PAC in the control and intervention arm were +3.3 ng/dL and +0.9 ng/dL, respectively (P=.04). The findings indicate that vitamin D3 supplementation significantly decreases PAC in patients with arterial hypertension and 25(OH)D insufficiency.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged - administration & dosage
-
Aldosterone - blood
-
Dietary Supplements - administration & dosage
-
Double-Blind Method - administration & dosage
-
Female - administration & dosage
-
Humans - administration & dosage
-
Hypertension - blood, complications
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Renin - blood
-
Treatment Outcome - administration & dosage
-
Vitamin D - administration & dosage, pharmacology
-
Vitamin D Deficiency - diet therapy, metabolism